The Leukemia & Lymphoma Society is working to end pediatric cancer.
While acute lymphoblastic leukemia (ALL) is the most common blood cancer associated with children, children and adolescents are impacted by many types of blood cancers. LLS supports pediatric and adolescent blood cancer patients through research, patient access, and advocacy & policy.
LLS-supported advances are saving lives and improving quality of life for children and adolescents with blood cancers. LLS currently supports approximately 15 projects focused specifically on pediatrics. In addition to our investment directly in pediatric and adolescent blood cancer programs, our investment in research for adult blood cancer patients can also be applied to children.
Thanks to research, more pediatric and adolescents with blood cancers are surviving. Since LLS began investing in research in 1949, the 5-year survival rate for children with ALL has improved from 5% to approximately 90%. It has taken decades to improve treatments and LLS has been there throughout this transition. But there is still much more to do- treatments for ALL do not cure all patients and the side effects from therapy can be long term.
In addition to long term side effects, there are social issues that patients and families face during and after a diagnosis. Locally, LLS is tackling this topic via our pediatric CARES (Cancer Advocacy, Resources, Education, & Support) Initiative. CARES supports pediatric families via education, peer-to-peer support, and the annual Children's Holiday Party, which provides local patients and their families with a special holiday experience complete with gifts, entertainment, and lunch. Over 300 people attend these programs.
Thank you for supporting all that LLS is doing to find an end to blood cancers!